🗞️ Meta’s Rx glasses

Bay Area Times··6 min read
AI/MLTechnologyBusiness
Share𝕏in

AI Summary

This tech newsletter covers major AI and business developments including Eli Lilly's $2.75B AI drug development deal with Insilico Medicine, Meta's upcoming prescription Ray-Ban smart glasses launch, and xAI losing its last original cofounder. The newsletter also discusses Physical Intelligence seeking $1B funding at $11B+ valuation and various AI model developments including Meta's Avocado variants.

Key Facts

Eli Lilly strikes $2.75B deal with Insilico Medicine for AI-developed drugs, with Insilico having created 28 GenAI drugs already in clinical stages.
Meta launches prescription Ray-Ban smart glasses this week targeting billions of prescription wearers, while testing multiple Avocado AI variants including a 9B model.
Physical Intelligence seeks $1B funding at $11B+ valuation as xAI loses its last original cofounder Ross Nordeen, ending Elon's founding team.

Author Takes

NeutralBay Area Times

AI chatbots

AI chatbots steer users toward moderate views while social media amplifies extremes

BullishBay Area Times

AI market expansion

AI agents could expand US market from $0.5T software to $6.2T labor market

Related topics

More from Bay Area Times

📰TodayFeed📡Signals💰Capital